The treatment of congenital diaphragmatic hernia (CDH) has always been a challenge for the pediatric surgen. After a few early optimistic reports the survival rate fell to around 50%, when surgeons started to operate on neonates and especially on newborns with symptoms within 24 hours. Despite new modalities of treatment the survival has remained at the same level during several decades. The high mortality is caused by the pulmonary hypoplasia, which always accompanies patients with CDH to a more or less severe extent. The pulmonary hypoplasia involves structural changes such as a reduced number of bronchial divisions, reduced number of alveoli and reduced number of vessels. There is a pronounced hypertrophy of the muscular layer of the arteriolies, which are abnormally reactive and easily contract causing a pulmonary vasospasm.
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Two of the most important stimuli causing a pulmonary vasospasm are hypoxemia and acidosis. When the pulmonary arteriolies contract, the pulmonary vascular resistance increases and the pulmonary artery pressure rises and if the latter exceeds the systemic blood pressure, the blood will shunt from right to left over the ductus arteriosus and the foramen ovaIe. The right to left shunt will further deteriorate the patients oxygenation and the patient will become more hypoxemic and acidotic, which again aggravates the pulmonary vasospasm. This vicious circle (Fig. 1) is seen in patients with severe pulmonary hypoplasia and must be broken if the patient is to survive.
Modern treatment
A number of drugs may decrease the pulmonary vascular resistance and many of these have been used in clinical treatment (Tab. I). A common problem is that they are not selective and consequently they also cause a systemic hypotension. Recently, however, nitric oxide has come into clinical practice. This substance, formerly known as EDRF (endothelium derived relaxing factor) (1), is normally synthetized in the endothelium cell and diffuses into the adjacent smooth muscle cell where it has a pronounced relaxing effect. Inhaled nitric oxide will have a selective relaxing effect on the pulmonary vessels, as due to its rapid metabolism it will never reach the systemic circulation. Kinsella et al (2) studied the clinical effect of nitric oxide in nine newborn patients with persistent pulmonary hypertension of the newborn (PPHN), who were candidates for ECMO. Two of their patients also had CDH. In all patients oxygenation promptly improved without a decrease in systemic blood pressure. Only one patient (not with CDH) subsequently required ECMO. Finer et al (3) reported results from 23 newborn ECMO referrals, of whom seven had CDH. All had oxygenation index of 20 or greater. Five of the seven CDH patients responded to nitric oxide and four of seven needed ECMO.
Classically, CDH has been considered as an emergency operation. Today, however, when it has become obvious that the main problem is the pulmonary hypoplasia and not the mechanical influence of abdominal viscera in the chest, immediate surgery has been questioned. As the pulmonary vascular bed is extremely reactive to various stimuli (4) the surgical procedure may by itself aggravate the vasospasm. The surgical repair may also have a negative effect on respiratory mechanics with a decreased compliance in the short period (5). Several groups have advocated delayed surgery with a prolonged preoperative stabilization (6-8), while others have failed to demonstrate any difference between immediate and delayed surgery (9, 10). All groups, however, seem to agree that there is no rush for surgery.
In order to break the vicious circle mentioned above, it might be proposed to surgically close the fetal shunts and especially the ductus arteriosus. A pulmonary vasospasm and a closed ductus, however, will obstruct the outflow of the right ventricle and cause a right heart failure. In consequence, no benefit has been published from ductus ligation.
Optimal ventilation might break the vicious circle and recruitment of atelectatic alveoli. In the lamb CDH model partial liquid ventilation resulted in significant improvement compared to conventional ventilation (19) . Its effect in human patients remains to be evaluated. Intratracheal pulmonary ventilation (ITPV) is a technique where the gas is delivered inside the endotracheal tube at the level of the carina with a special device constructed by Kolobow et al (20) . The continuous gas flow is directed upwards.
When the patient is to inspirate, the outflow from the endotracheal tube is obstructed, so the lungs are filled with gas. During the expiration the outflow from the endotracheal tube is opened. The expiration is mainly passive but it is facilitated by the Venturi effect of the continuous gasflow directed upwards.
Hypoxemia Acidosis
by improving oxygenation. The lungs are not only hypoplastic, but also have an immature appearance. They are probably more sensitive to barotrauma and hyperoxygenic trauma than mature lungs.
High frequency ventilation (HFV), mostly defined as a ventilation with a frequency over four times the normal and a tidal volume close to or less than dead space, may reduce the barotrauma. In high frequency oscillation ventilation (HFOV or HFO) frequencies around 10Hz are used. Varholt et al (11) (12) . Among 122 neonates meeting ECMO criteria treated with HFOV there were 65 responders, who never needed ECMO. Among patients with CDH/lung hypoplasia there were however only 5 responders out of 20. Cornish and Clark (13) also concluded that HFOV is less effective among CDH patients than in other ECMO candidates in their study of 112 neonates.
The immature appearance of CDH lungs resembles that of the lungs in premature infants and CDH patients are also deficient of surfactant (14) . Decreased LIS ratios have been shown in amniotic fluid analysis. Glick et al (15) have shown decreased surfactant in the fetal lamb model. Administration of exogenous surfactant before the first breath significantly improved gas exchange and lung compliance (16) . In the rat model with nitrofen induced CDH, exogenous surfactant was however without effect (17). Lotze et al (18) randomized CDH patients on ECMO and gave nine patients surfactant. Time on ECMO and lung compliance was the same as in the eight controls.
Liquid ventilation with perfluorocarbons is an interesting technique. The oxygen and carbon dioxide carrying capacity of perfluorocarbons is excellent. The ventilation can be performed by either of two techniques. In total liquid ventilation lungs, airways and the "ventilator" are filled with the liquid and the "ventilator" gives tidal volumes of perfluorocarbon. Partial liquid ventilation is technically easier and involves gas ventilation of perfluorocarbon filled lungs. The advantageous effect of liquid ventilation is probably due to improved ventilation/perfusion relationship The method controls gas exchange until the pulmonary vasospasm improves. The extracorporeal flow can thereby gradually be decreased and subsequently the extracorporeal support can be withdrawn. The advantage of ECMO is obvious but it is a highly invasive and also a costly procedure.
Today there is large world wide accumulated experience of ECMO treatment of COH with over 1800 cases reported to the central registry 1994 (22) . The overall survival among these patients was 58%.
It is important to keep in mind that the different techniques outlined above should be considered complementary and not competitive in the treatment of congenital diaphragmatic hernia. The optimal treatment of COH is an ideal combination of the different methods. However what is "ideal" is still a matter of debate.
The current strategy in our institution is outlined in Figure 2 . If the patient is stable on conservative treatment the hernia will be repaired but after a delay of mostly 3-4 days. If the patient is not stable on conservative treatment, nitric oxide and HFOV will be tried. If the patient stabilizes, the hernia will be repaired after a delay of 3 or 4 days. If the patient does not stabilize on nitre oxide or HFOV he is put on ECMO if standard ECMO criteria are fulfilled. If the criteria are not met, conservative treatment is continued until the patient either stabilizes or deteriorates. One main question is how "stable" is defined. A general accepted definition has not been given, but we would require normal blood gases with no right to left shunting on a gentle conventional ventilation with Fi0 2 < 0.4.
Our experience
No ---------' The main advantage of ITPV is the reduced dead space and facilitation of expiration. It has been advantageous in animal studies. Wilson et al (21) have used the technique in two patients with COH, who could not be weaned from ECMO. The patients were put on ITPV and could subsequently be weaned.
The most direct way to improve the patients oxygenation is to put the patient on ECMO. This is a modified heart-lung machine and the blood is directly oxygenated through the artificial lung (oxygenator).
Since the current strategy outlined above was adopted in 1990, 46 patients with congenital diaphragmatic hernia have been treated (23) (Fig. 3) . Nine out of fortysix patients did not develop symptoms within the first 6 hours and all these nine patients survived. The remaining 37 patients were critically ill with symptoms within 6 hours. Twentyseven did not meet ECMO criteria and all survived. Ten patients met ECMO-criteria but 4 had contraindications and were not treated with ECMO. These four patients died. The six patients who were treated with ECMO all survived. The indication for ECMO was either oxygenation index > 45 or rapid deterioration. The average time on ECMO was 14 days (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) . All patients were put on ECMO in the preoperative stabilization phase and four were operated while still on ECMO but two could be decannulated and operated on later. Although all ECMO patients survived there were several significant complications, mainly from bleeding. Altogether four out of the 46 patients died and all four patients had contraindications for ECMO. Three were premature with a BW 1400 -1800 g and one had a chromosomal aberration. The survival in this material is extremely high and it is natural to ask oneself if the figures represent the true survival rate. Of course, there is the influence of chance and we have been lucky because during this period we did not receive a patient with such a pronounced pulmonary hypoplasia as to be incompatible with life. Furthermore as there is no maternity unit in our institution all patients have been transported, which theoretically might cause a selection.
However, there were no deaths during transportation and there were no deaths among the prenatally diagnosed patients. The present survival rate is significantly higher than the survival in the same institution before ECMO was available 1987 (58%, (24) ).
To illustrate the difficulties, the following case is shortly presented. A boy with a prenatally diagnosed CDH rapidly deteriorated after delivery. Nitric oxide and HFOV were without persistent effect. The baby was put on veno-arterial ECMO and the perfusion was initiallly uneventful. On day 6 a right chest tube was inserted due to a massive pleural exudation. There was an increase in bleeding from the right chest and on day 13 a minithoracotomy was performed in order to stop the bleeding. This was without effect and on day 14 the circuit was changed, aprotinin was given as an antifibrinolytic drug and a regular thoracotomy was performed where large quantities of coagulated blood were removed. The following day the left-sided hernia was repaired. After these two major operations there was no significant bleeding, but 12 hours later the venous cannula had to be replaced due to clotting. The pulmonary functions improved the following days and on day 19 the patient could be decannulated. Fifteen days post ECMO he was extubated.
In conclusion, the modern treatment of congenital diaphragmatic hernia involves several new complentary technologies such as CDH which improved the clinical results. ECMO appears an important corner-stone in this field and requires professional personel.
